OWC Pharmaceutical Research Corp (OWCP)

[Triple9]

Phase 1+2+3 FDA clinical trials cost an average of US $1.3 Billion dollars according to Forbes:

http://www.forbes.com/sites/theapothecary/2014/01/24/shocking-secrets-of-fda-clinical-trials-revealed/#3aa9df232279

OWCP has been doing IRB trials in Israel because the cost is much lower and the R&D environment is very cannabis friendly. That's why $OWCP Longs know we have a huge advantage over all other pre-revenue MMJ biotechs.

You can see, however, that US FDA clinical trials are the world wide Gold standard, and that's why OWCP has just filed for Phase 1 for the psoriasis cream.